Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer.

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Gazimuhtar Paşa Bulvarı
No:36
27090
Şehitkamil / GAZİANTEP